Oct 13 (Reuters)-
Cosmos Pharmaceutical
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Aug 31, 2026 Aug 31, 2025 May 31, 2027
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 286.65 272.39 1.19 trln
(+5.2 pct) (+4.0 pct) (+8.2 pct)
Operating 12.01 11.65 43.00
(+3.1 pct) (+0.6 pct) (+1.5 pct)
Recurring 12.77 12.19 45.70
(+4.7 pct) (-0.9 pct) (+2.4 pct)
Net 8.25 8.17 30.70
(+1.0 pct) (+0.3 pct) (-4.2 pct)
EPS 104.11 yen 103.10 yen 387.35 yen
Ann Div -- 82.00 yen 84.00 yen
-Q2 div -- 37.50 yen 42.00 yen
-Q4 div -- 44.50 yen 42.00 yen
NOTE - Cosmos Pharmaceutical.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T